Wednesday, July 8, 2026

Drug profile · INN

oxycodone hydrochloride

oxycodone hydrochloride (OXYCODONE HYDROCHLORIDE) is a mu opioid receptor agonist. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 1
News articles 2
Drug details — oxycodone hydrochloride

Quick answer

oxycodone hydrochloride (OXYCODONE HYDROCHLORIDE) is a mu opioid receptor agonist. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN oxycodone hydrochloride
Brand OXYCODONE HYDROCHLORIDE
Mechanism Mu opioid receptor agonist
Target Mu-type opioid receptor
Route ORAL
Formulation TABLET, EXTENDED RELEASE

Mechanism of action

Mu opioid receptor agonist

Primary target: Mu-type opioid receptor

Approval history

Authority Status Date
FDA approved

Recent coverage

Pipeline programs

  1. Oxycodone Hydrochloride Approved · Chinese Academy of · Analgesia, Patient-Controlled

Related & competitor drugs

  1. alvimopan Mu opioid receptor antagonist
  2. loperamide hydrochloride Mu opioid receptor agonist
  3. methadone hydrochloride Mu opioid receptor agonist
  4. morphine sulfate Mu opioid receptor agonist
  5. oxycodone Mu opioid receptor agonist
  6. propoxyphene hydrochloride Mu opioid receptor agonist

Frequently asked questions

What is oxycodone hydrochloride?

oxycodone hydrochloride (OXYCODONE HYDROCHLORIDE) is a mu opioid receptor agonist. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for oxycodone hydrochloride?

OXYCODONE HYDROCHLORIDE is a marketed brand name for oxycodone hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of oxycodone hydrochloride?

oxycodone hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.